GeneDx (WGS) PT Lowered to $100 at Canaccord

April 20, 2026 7:37 AM

Canaccord analyst Kyle Mikson lowered the price target on GeneDx (NASDAQ: WGS) to $100.00 (from $170.00) while maintaining a Buy rating.

No results found